BPC-157 + GHK-Cu + TB-500
BPC-157 + GHK-Cu + TB-500
- 10 mg + 50 mg + 10 mg (70 mg total)
$195.00
Documentation pending
KLOW
Co-formulated blend: GHK-Cu (copper tripeptide-1), TB-500 (thymosin beta-4 fragment), BPC-157 (pentadecapeptide), and KPV (lysine-proline-valine tripeptide)
- SKU family:
- KLOW
- Format:
- Lyophilised powder, sealed glass vial
Four-component lyophilised research blend with total nominal fill stated.
$200.00
100 in stock
1
Research use only. For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use, diagnostic use, or any form of administration.
No published batch record for this material yet.
Overview
KLOW is a co-formulated research blend. Every component is named by its chemical identity on the label, in the batch record, and on this page — the blend name is a convenience label, not a substitute for identity.
Research
Blend of four independently described peptides. Component-level nominal fills are listed in the batch record for each lot.
Documentation
No published batch record exists for this material yet. We do not state identity, purity, mass, sterility, or endotoxin status without a report for the exact lot.
FAQ
Related materials
BPC-157 + TB-500
Co-formulated blend: BPC-157 (synthetic pentadecapeptide) and TB-500 (synthetic thymosin beta-4 fragment)
- 5 mg + 5 mg (10 mg total)
- 10 mg + 10 mg (20 mg total)
$100.00
Documentation pending
BPC-157 + TB-500 + KPV
BPC-157 + TB-500 + KPV
- 10 mg + 10 mg + 10 mg (30 mg total)
$127.00
Documentation pending
CJC-1295 without DAC + Ipamorelin
Co-formulated blend: CJC-1295 without DAC (modified GRF 1-29) and Ipamorelin (synthetic pentapeptide secretagogue)
- 5 mg + 5 mg (10 mg total)
$112.00
Documentation pending
KLOW · 10 mg + 50 mg + 10 mg + 10 mg (80 mg total)
$200.00